BIAF | | bioAffinity Technologies, Inc. | DIAMOND STUART | Director | Oct 01, 2023 | Option Exercise | $1.58 | 11,867 | 18,750 | 44,340 | Jan 24, 2024, 08:52 PM |
BIAF | | bioAffinity Technologies, Inc. | DIAMOND STUART | Director | Jan 01, 2024 | Option Exercise | $1.48 | 12,668 | 18,749 | 57,008 | Jan 24, 2024, 08:52 PM |
BIAF | | bioAffinity Technologies, Inc. | DIAMOND STUART | Director | Jan 01, 2023 | Option Exercise | $2.28 | 8,227 | 18,758 | 12,308 | Jul 06, 2023, 04:15 PM |
BIAF | | bioAffinity Technologies, Inc. | DIAMOND STUART | Director | Apr 15, 2023 | Option Exercise | $1.89 | 9,920 | 18,749 | 22,228 | Jul 06, 2023, 04:15 PM |
BIAF | | bioAffinity Technologies, Inc. | DIAMOND STUART | Director | Jul 01, 2023 | Option Exercise | $1.83 | 10,245 | 18,748 | 32,473 | Jul 06, 2023, 04:15 PM |
MRX | | MEDICIS PHARMACEUTICAL CORP | DIAMOND STUART | Director | Dec 11, 2012 | Option Exercise | $44.00 | 8,675 | 381,700 | 0 | Dec 13, 2012, 04:15 PM |
MRX | | MEDICIS PHARMACEUTICAL CORP | DIAMOND STUART | Director | Aug 20, 2012 | Option Exercise | $22.40 | 17,500 | 392,000 | 26,175 | Aug 22, 2012, 06:00 PM |
MRX | | MEDICIS PHARMACEUTICAL CORP | DIAMOND STUART | Director | Aug 20, 2012 | Sale | $32.76 | 17,500 | 573,318 | 8,675 | Aug 22, 2012, 06:00 PM |
MRX | | MEDICIS PHARMACEUTICAL CORP | DIAMOND STUART | Director | Apr 29, 2011 | Option Exercise | $37.18 | 9 | 335 | 3,953 | May 19, 2011, 08:05 PM |